Trends in In-Hospital Outcomes Among Adults Hospitalized With Exacerbation of Chronic Obstructive Pulmonary Disease

References

• MurrayCJ, LopezAD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349:1498–1504.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. Data Fact Sheet: Chronic Obstructive Pulmonary Disease. Report no. 03-5229. Bethesda, MD: National Heart, Lung, and Blood Institute; 2003.
   Google Scholar
• Miniño AM, XuJQ, Kochanek K. Deaths: preliminary data for 2008. Natl Vital Stat Rep 2010; 59:7.
   Google Scholar
• National Heart Lung and Blood Institute. Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Heart, Lung, and Blood Institute, 2009.
   Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007; 370:786–795.
   PubMed Web of Science ®Google Scholar
• Snow V, LascherS, Mottur-Pilson C. Joint expert panel on chronic obstructive pulmonary disease of the American College of Chest Physicians and the American College of Physicians-American Society of Internal Medicine. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2001; 134:595–599.
   PubMed Web of Science ®Google Scholar
• McGarvey LP, MatthiasJ, AndersonJA, et al. Ascertainment of cause-specific mortality in COPD: operations of the torch clinical endpoint committee. Thorax 2007; 62:411–415.
   PubMed Web of Science ®Google Scholar
• Calverley PM, AndersonJA, CelliB, et al. Salmeterol and fluticasone propionate and survival in chronic obstructvie pulmonary disease. N Engl J Med 2007; 356:775–789.
   PubMed Web of Science ®Google Scholar
• Lee TA, WilkeC, Joo M, et al. Outcomes associated with tiotropium. Arch Intern Med 2009; 169:1403–1411.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Senn S, et al. The 4-year trial of tiotropiumin chronic obstructive pulmonary disease. N Engl J Med 2008; 359:1543–1554.
   PubMed Web of Science ®Google Scholar
• Calverley PM, RennardSI. What have we learned from large drug treatment trials in COPD? Lancet 2007; 370:774–785.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011 Aug 2; 155(3):179–91.
   PubMed Web of Science ®Google Scholar
• ManninoDA, BuistSA. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370:765–773.
   PubMed Web of Science ®Google Scholar
• Baillargeon J, Wang Y, Kuo YF, et al. Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease. Am J Med 2013; 126(7):607–614.
   Google Scholar
• SorianoJB, AncocheaJ, MiravitllesM, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. Eur Respir J 2010; 36:758–765.
   PubMed Web of Science ®Google Scholar
• Gershon AS, Wang C, Wilton AS, et al. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: A Population Based Study. Arch Intern Med 2010; 170(6):560–565.
   PubMed Web of Science ®Google Scholar
• Simpson CR, Hippisley J, Sheikh A. Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51,804 patients. Br J Gene Pract 2010; e277–e284.
   Google Scholar
• Tan WC. Trends in chronic obstructive pulmonary disease in the Asia-Pacific regions. Curr Opin Pulm Med 2011; 17:56–61.
   PubMed Web of Science ®Google Scholar
• Ekstrom MP, Wagner P, StromKE. Trends in Cause-Specific Mortality in Oxygen-dependent Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2011; 183:1032–1036.
   PubMed Web of Science ®Google Scholar
• de Miguel-Diaz J, Jimenez-Garcia R, Hernandez-Barrera V, et al. Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med 2013; 107:717–723.
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012; 67:957–963.
   PubMed Web of Science ®Google Scholar
• FordES. Hospital discharges, readmissions, and emergency department visits for chronic obstructive pulmonary disease or bronchiectasis among U.S. adults: findings from the Nationwide Inpatient Sample 2001-2012 and Nationwide Emergency Department Sample 2006–2011. Chest 2014 [epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Thun MJ, Carter BD, FeskanichD, et al. 50-year trends in smoking-related mortality in the United States. New Eng J Med 2013; 368(4):351–364.
   Google Scholar
• RamFS, PicotJ, LightowlerJ, WedzichaJA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004; 3:CD004104.
   PubMedGoogle Scholar
• Stefan MS, Shieh MS, Pekow PS, et al. Trends in mechanical ventilation among patients hospitalized with acute exacerbation of COPD in the United States, 2001 to 2011. Chest 2014 [epub ahead of print].
   Web of Science ®Google Scholar
• TagaS, Taniguchi H, Watanabe N, et al. Predictors of the need to initiate noninvasive ventilation in stable oupatients with acute exacerbation of chronic obstructive pulmonary disease. Intern Med 2013; 52:1781–1786.
   PubMed Web of Science ®Google Scholar
• Dalal AA, LiuF, Riedel AA. Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009. Int J Chron Obstruct Pulmon Dis 2011; 6:533–542.
   PubMed Web of Science ®Google Scholar
• DalalAA, ChristensenL, LiuF, Riedel AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis 2010; 5:341–349.
   PubMedGoogle Scholar
• Dalal AA, ShahM, D'SouzaAO, RaneP. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med 2011; 105(3):454–460.
   PubMed Web of Science ®Google Scholar
• CruzJ, Brooks D, MarquesA. Home telemonitoring effectiveness in COPD: a systematic review. Int J Clin Pract 2014; 68(3):368–378.
   Web of Science ®Google Scholar
• Stein BD, Bautista A, SchumockGT, et al. The validity of ICD-9-CM diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest 2012; 141:87–93.
   PubMed Web of Science ®Google Scholar